MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-08-0023639
Sires Biotics Private Limited
Sires Biotics Private Limited - business services in Nizamabad, Telangana, India. Directors, charges & compliance details.
Revenue · FY 2025
₹36.25 Lakh
Latest filing
Net profit · FY 2025
₹80,500
Net margin 2.2%
EBITDA · FY 2025
₹80,500
EBITDA margin 2.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Sires Biotics Private Limited
Data last updated:
Sires Biotics Private Limited is a private limited company based in Nizamabad, Telangana, India. It was incorporated on 12 April 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U47721TS2023PTC171906.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohammed Abdul Umair and Mohammed Abdul Maaz.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nizamabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.25 Lakh. For the same year it recorded a net profit of ₹80,500 (net margin 2.2%) and EBITDA of ₹80,500 (EBITDA margin 2.2%).
Sires Biotics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-08-0023639).
Company details
CIN U47721TS2023PTC171906
Registration Number 171906
Incorporation Date 12 April 2023
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-08-0023639
Recognitions & Rankings of Sires Biotics
Contact details
Sires Biotics Private Limited's registered office is in Nizamabad, Telangana.
- Registered Address8 – 1 – 24 L1 Behind Minar Bakery, Near Bodhan Bustand, Nizamabad, Telangana, India – 503001
Comprehensive company report
Sires Biotics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sires Biotics is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Sires Biotics Private Limited, buy the company report.
Financials of Sires Biotics Private Limited
FY 2025 filings availableSires Biotics Private Limited reported revenue of ₹36.25 Lakh for FY 2025.
Revenue · FY 2025
₹36.25 Lakh
Net profit · FY 2025
₹80,500 margin 2.2%
EBITDA · FY 2025
₹80,500 margin 2.2%
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹80,500 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹80,500 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.2% | |
| Net Profit Margin | 2.2% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Sires Biotics Private Limited, buy the company report.
Board of directors of Sires Biotics Private Limited
Sires Biotics has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammed Abdul Umair | Director | 12 Apr 2023 | 3 Years 6 Months | Current |
| Mohammed Abdul Maaz | Director | 12 Apr 2023 | 3 Years 6 Months | Current |
| Hamid Bin Haqani | Director | 12 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Sires Biotics Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Achillea Life Sciences Private Limited | ₹36.79 Lakh (FY 2024) | -27.0% | Mumbai, Maharashtra, India | |||
| Letcure Pharmaceuticals Private Limited | ₹36.71 Lakh (FY 2025) | 7.0% | Thane, Maharashtra, India | |||
| Garnichem Pharma Private Limited | ₹36.64 Lakh (FY 2025) | 31.0% | Vasai, Maharashtra, India | |||
| Tableen Health Care Private Limited | ₹36.46 Lakh (FY 2025) | 504.0% | Rajganj, West Bengal, India | |||
| Misika Drugs and Herbs Private Limited | ₹36.32 Lakh (FY 2024) | 0.0% | New Delhi, Delhi, India | |||
| Sires Biotics Private Limitedthis company | ₹36.25 Lakh (FY 2025) | ₹80,500 | 2.2% | Nizamabad, Telangana, India | ||
| Metabolyte Life Sciences Private Limited | ₹35.91 Lakh (FY 2024) | 162.0% | Bangalore, Karnataka, India | |||
| Advanced Qa Services (OPC) Private Limited | ₹35.77 Lakh (FY 2025) | Chennai, Tamil Nadu, India | ||||
| Nature Life Remedies Private Limited | ₹35.15 Lakh (FY 2025) | -6.0% | Pune, Maharashtra, India | |||
| Avychem Pharma Private Limited | ₹34.51 Lakh (FY 2025) | 41.0% | Bilaspur, Haryana, India | |||
| Cetus Pharmaceutical Private Limited | ₹34.11 Lakh (FY 2025) | 31.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Sires Biotics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sires Biotics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sires Biotics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sires Biotics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sires Biotics Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Hamid Bin Haqani was appointed as Director on 12 Apr 2023.
AGM
Sires Biotics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sires Biotics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Hamid Bin Haqani was appointed as Director.
Appointed
Mohammed Abdul Maaz was appointed as Director.
Appointed
Mohammed Abdul Umair was appointed as Director.
Incorporation
12 Apr 2023
Sires Biotics Private Limited was registered on 12 Apr 2023 with Roc Hyderabad & aged 3 years 6 months as per MCA records.
Frequently asked questions
Sires Biotics is an active private limited company based in Nizamabad, Telangana, India. It was incorporated on 12 April 2023 (3+ years old) and is registered under CIN U47721TS2023PTC171906.
Sires Biotics has 3 current directors:
- Mohammed Abdul Umair - Director
- Mohammed Abdul Maaz - Director
- Hamid Bin Haqani - Director
The latest financial statements of Sires Biotics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Sires Biotics is U47721TS2023PTC171906. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sires Biotics was incorporated on 12 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sires Biotics by revenue are Achillea Life Sciences Private Limited, Letcure Pharmaceuticals Private Limited, Garnichem Pharma Private Limited, Tableen Health Care Private Limited, Misika Drugs and Herbs Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Hamid Bin Haqani was appointed as Director on 12 Apr 2023. Mohammed Abdul Maaz was appointed as Director on 12 Apr 2023. Mohammed Abdul Umair was appointed as Director on 12 Apr 2023.
Yes, Sires Biotics is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-08-0023639).
The registered office of Sires Biotics is at 8 – 1 – 24 L1 Behind Minar Bakery, Near Bodhan Bustand, Nizamabad, Telangana, India – 503001.
Sires Biotics can be reached at its registered office: 8 – 1 – 24 L1 Behind Minar Bakery, Near Bodhan Bustand, Nizamabad, Telangana, India – 503001.
Sires Biotics is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.